Literature DB >> 33679730

Less Severe Cases of COVID-19 in Sub-Saharan Africa: Could Co-infection or a Recent History of Plasmodium falciparum Infection Be Protective?

Allan Kalungi1,2,3, Eugene Kinyanda1,2, Dickens Howard Akena2, Pontiano Kaleebu4, Innocent M Bisangwa5.   

Abstract

Sub-Saharan Africa has generally experienced few cases and deaths of coronavirus disease 2019 (COVID-19). In addition to other potential explanations for the few cases and deaths of COVID-19 such as the population socio-demographics, early lockdown measures and the possibility of under reporting, we hypothesize in this mini review that individuals with a recent history of malaria infection may be protected against infection or severe form of COVID-19. Given that both the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Plasmodium falciparum (P. falciparum) merozoites bind to the cluster of differentiation 147 (CD147) immunoglobulin, we hypothesize that the immunological memory against P. falciparum merozoites primes SARS-CoV-2 infected cells for early phagocytosis, hence protecting individuals with a recent P. falciparum infection against COVID-19 infection or severity. This mini review therefore discusses the potential biological link between P. falciparum infection and COVID-19 infection or severity and further highlights the importance of CD147 immunoglobulin as an entry point for both SARS-CoV-2 and P. falciparum into host cells.
Copyright © 2021 Kalungi, Kinyanda, Akena, Kaleebu and Bisangwa.

Entities:  

Keywords:  COVID-19; Plasmodium falciparum infection; SARS–CoV-2; Sub-Saharan Africa; co-infection

Year:  2021        PMID: 33679730      PMCID: PMC7930213          DOI: 10.3389/fimmu.2021.565625

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  9 in total

Review 1.  Cellular Therapy: The Hope for Covid-19.

Authors:  Sima Nobari; Motahareh Rezvan; Fariba Dashtestani; Mahdieh Gangi; Hoda Keshmiri Neghab
Journal:  Avicenna J Med Biotechnol       Date:  2022 Apr-Jun

Review 2.  CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target.

Authors:  Tapan Behl; Ishnoor Kaur; Lotfi Aleya; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Saurabh Bhatia; Ahmed Al-Harrasi; Simona Bungau
Journal:  Sci Total Environ       Date:  2021-12-01       Impact factor: 7.963

3.  High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers.

Authors:  Fikadu G Tafesse; Alemseged Abdissa; Tesfaye Gelanew; Berhanu Seyoum; Andargachew Mulu; Adane Mihret; Markos Abebe; Liya Wassie; Baye Gelaw; Abebe Sorsa; Yared Merid; Yilkal Muchie; Zelalem Teklemariam; Bezalem Tesfaye; Mahlet Osman; Gutema Jebessa; Abay Atinafu; Tsegaye Hailu; Antenehe Habte; Dagaga Kenea; Anteneh Gadisa; Desalegn Admasu; Emnet Tesfaye; Timothy A Bates; Jote Tafese Bulcha; Rea Tschopp; Dareskedar Tsehay; Kim Mullholand; Rawleigh Howe; Abebe Genetu
Journal:  BMC Infect Dis       Date:  2022-03-16       Impact factor: 3.667

4.  Impact of COVID-19 and malaria coinfection on clinical outcomes: a retrospective cohort study.

Authors:  Rasha Hussein; Murilo Guedes; Nada Ibraheim; Mazin M Ali; Amal El-Tahir; Nahla Allam; Hussain Abuakar; Roberto Pecoits-Filho; Peter Kotanko
Journal:  Clin Microbiol Infect       Date:  2022-03-31       Impact factor: 13.310

5.  SARS-CoV-2 and Plasmodium falciparum Co-Infection in a Returning Traveler.

Authors:  Qian Huang; Wen-Jie Xu; Xiao-Xiao Wang; Xuan Zhang; Ke-Nu Pan; Jia-Qi Zhang; Hua-Liang Chen; Wei Ruan; Li-Nong Yao
Journal:  Front Public Health       Date:  2022-08-05

6.  Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa.

Authors:  Kesego Tapela; Fatima O Oyawoye; Charles Ochieng' Olwal; Precious C Opurum; Jones Amo Amponsah; Kekeli Aku Lumor Segbedzi; Becky Tetteh; Frederick Kumi-Ansah; Joe K Mutungi; Evangeline Obodai; Emmanuella Amoako; Seth Agyemang; Nicaise Tuikue Ndam; William Kwabena Ampofo; Julian C Rayner; Gordon A Awandare; Lily Paemka; Yaw Bediako; Peter Kojo Quashie
Journal:  BMC Med       Date:  2022-10-03       Impact factor: 11.150

7.  High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers.

Authors:  Tesfaye Gelanew; Berhanu Seyoum; Andargachew Mulu; Adane Mihret; Markos Abebe; Liya Wassie; Baye Gelaw; Abebe Sorsa; Yared Merid; Yilkal Muchie; Zelalem Teklemariam; Bezalem Tesfaye; Mahlet Osman; Gutema Jebessa; Abay Atinafu; Tsegaye Hailu; Antenehe Habte; Dagaga Kenea; Anteneh Gadissa; Desalegn Admasu; Emmet Tesfaye; Timothy A Bates; Jote Bulcha; Rea Tschopp; Dareskedar Tsehay; Kim Mullholand; Rawleigh Howe; Abebe Genetu; Fikadu G Tafesse; Alemseged Abdissa
Journal:  Res Sq       Date:  2021-07-19

8.  COVID-19 Antibody Detecting Rapid Diagnostic Tests Show High Cross-Reactivity When Challenged with Pre-Pandemic Malaria, Schistosomiasis and Dengue Samples.

Authors:  Fien Vanroye; Dorien Van den Bossche; Isabel Brosius; Bieke Tack; Marjan Van Esbroeck; Jan Jacobs
Journal:  Diagnostics (Basel)       Date:  2021-06-25

9.  COVID-19: The African enigma.

Authors:  Robert Colebunders
Journal:  Colomb Med (Cali)       Date:  2021-04-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.